Latest papers

VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.

Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates.

Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs.

[A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508]

Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.

The long-term effect of tetrabenazine in the management of Huntington disease.

[Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters].

Tourette's syndrome and role of tetrabenazine: review and personal experience.

Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.

[Use of 11C-(+)-alpha -dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease].

Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment

Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.

New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine.

Neurotransmitter depleter tetrabenazine; potential candidate for schizophrenia treatment?

Specific derivatization of the vesicle monoamine transporter with novel carrier-free radioiodinated reserpine and tetrabenazine photoaffinity labels.

Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP.

In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.

Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients.

Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2.